Walking Through Elephant Cancer Resistance: What it can teach us about elephants, genetics and disease defenses
DOI:
https://doi.org/10.47611/jsrhs.v12i4.5377Keywords:
Tumor suppressor genes, Cancer, Peto’s Paradox, Benign tumors, Malign tumors, Apoptosis, retrotransposition, pseudogenes, Gene mutationsAbstract
Cancer is a disease that affects the whole animal kingdom, but it does not behave equally in all the species. Elephants are one of the animals that even though have a greater number of cells in their body they present a low cancer rate. This phenomenon is also known as the Peto’s Paradox. Scientists have concluded that elephants have greater immunity to cancer because their genome has extra copies of tumor suppressor genes: TP53 and LIF. Even though elephants have a big immunity to cancer, they still get the disease, for example Asian elephants are more susceptible of getting reproductive tract neoplasia. Exploring this information is essential to understand how cancer behaves and how our own genes could help us fight the disease. This paper is a review of the actual knowledge the scientific community has regarding how cancer works in elephants, with the final goal of exploring the meaning this has into our understanding of genomics and how it could help us to develop a cure for cancer.
Downloads
References or Bibliography
Abegglen, L. M., Harrison, T. M., Moresco, A., Fowles, J. S., Troan, B. V., Kiso, W. K., ... &
Schiffman, J. D. (2022). Of Elephants and Other Mammals: A Comparative Review of
Reproductive Tumors and Potential Impact on Conservation. Animals, 12(15), 2005.
https://goi.org/10.339-/ani12152005
Callaway, E. (2015). How elephants avoid cancer. Nature, 1038, 18534.https://doi.org/10.1038/nature.2015.18534
Callier, V. (2019). Solving Peto’s Paradox to better understand cancer. Proceedings of the National
Academy of Sciences, 116(6), 1825-1828. https://doi.org/10.1073/pnas.182151711
Gaughran, Stephen J., Evlyn Pless, and Stephen C. Stearns. "How elephants beat cancer."
Elife 5 (2016): e21864. https://doi.org/10.7554/eLife.21864
Hassin, O., & Oren, M. (2023). Drugging p53 in cancer: one protein, many targets. Nature Reviews
Drug Discovery, 22(2), 127-144. https://doi.org/10.1038/s41573-022-00571-8
Haupt, S., & Haupt, Y. (2017). P53 at the start of the 21st century: lessons from elephants.
F1000Research, 6. https://doi.org/ 10.12688/1000research.12682.1
Landolfi, J. A., Gaffney, P. M., McManamon, R., Gottdenker, N. L., Ellis, A. E., Rech, R. R., ... &
Pessier, A. P. (2021). Reproductive tract neoplasia in adult female Asian elephants (Elephas
maximus). Veterinary pathology, 58(6), 1131-1141. https://doi.org/10.1177/03009858211031843
Nery, M. F., Rennó, M., Picorelli, A., & Ramos, E. (2022). A phylogenetic review of cancer resistance highlights
evolutionary solutions to Peto’s Paradox. Genetics and Molecular Biology, 45. https://doi.org/10.1590/1678-4685-GMB-2022-0133
Nunney, L. (2022). Cancer suppression and the evolution of multiple retrogene copies of TP53 in
elephants: A re‐evaluation. Evolutionary Applications, 15(5), 891-901. https://doi.org/10.1111/eva.13383
Padariya, M., Jooste, M. L., Hupp, T., Fåhraeus, R., Vojtesek, B., Vollrath, F., ... & Karakostis, K.
(2022). The elephant evolved p53 isoforms that escape MDM2-mediated repression and cancer.
Molecular biology and evolution, 39(7), msac149. https://doi.org/10.1093/molbev/masac149
Preston, A. J., Rogers, A., Sharp, M., Mitchell, G., Toruno, C., Barney, B. B., ... & Abegglen, L. M. (2023).
Elephant TP53-RETROGENE 9 induces transcription-independent apoptosis at the mitochondria. Cell
Death Discovery, 9(1), 66. https://doi.org/10.1038/s41420-023-01348-7
Rebel Cell: Cancer, Evolution and the New Science of Life’s oldest Betrayal, Arney 2020, BenBella Books. Inc.
Staszak, K., & Makałowska, I. (2021). Cancer, retrogenes, and evolution. Life, 11(1), 72.
https://doi.org/10.3390/life11010072
Tollis, M., Ferris, E., Campbell, M. S., Harris, V. K., Rupp, S. M., Harrison, T. M., ... & Abegglen, L.
M. (2021). Elephant genomes reveal accelerated evolution in mechanisms underlying disease
defenses. Molecular biology and evolution, 38(9), 3606-3620. https://10.1093/molbev/msab127
Vazquez, J. M., Sulak, M., Chigurupati, S., & Lynch, V. J. (2018). A zombie LIF gene in elephants is
upregulated by TP53 to induce apoptosis in response to DNA damage. Cell reports, 24(7), 1765-1776.
https://doi.org/10.1016/j.celrep.2018.07042
Vazquez, J. M., & Lynch, V. J. (2021). Pervasive duplication of tumor suppressors in Afrotherians
during the evolution of large bodies and reduced cancer risk. Elife, 10, e65041.
https://doi.org/10.7554/eLife.65041
Voskarides, K., & Giannopoulou, N. (2023). The role of TP53 in adaptation and evolution. Cells, 12(3),
Published
How to Cite
Issue
Section
Copyright (c) 2023 Luna Reyes Castro; Ioana Cimpean, Lyda Raquel Castro Garcia
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright holder(s) granted JSR a perpetual, non-exclusive license to distriute & display this article.
